A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

In 2010, the Medtronic Symplicity Spyral device was the first to receive ... Afferent nerves signal the central sympathetic activity leading to reflex sympathetic activation, peripheral ...

New guidance for clinicians for the evaluation and management of patients with lower extremity peripheral artery disease (LE PAD) was published in May. The 2024 ACC/AHA guideline for LE PAD, the first ...

Ajizian held multiple positions in his more than nine years at Medtronic. In 2020, the company made Ajizian CMO of patient monitoring. Two years later, Medtronic outlined plans to spin off its ...

More than half of patients with gout from the study cohort reported experiencing peripheral neuropathy. A high prevalence of neuropathy exists among patients with gout, with key associations found ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...